SSSeema Sen

Seema Sen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seema Sen has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    980 Prognostic significance of M1/M2 tumor-associated macrophages with pigmentation in uveal melanoma

    by Jayanti Jha, Lata Singh, Mithalesh Singh, Rachna Meel, Neelam Pushker, Neiwete Lomi, Aanchal Kakkar, Seema Sen, Seema Kashyap

    Background Tumor-Associated Macrophages (TAMs) are associated with an unfavorable outcome in uveal melanoma (UM). Literature showed the correlation between UM with monosomy 3 and an inflammatory phenotype including the presence of TAMs.1 TAMs in UM with monosomy 3 are predominantly pro-angiogenic M2 polarized macrophages which are characterized by CD163. They promote tumor progression and produce cytokines IL 10 in high amounts. Whereas M1 which is characterized by CD68 is generally considered a potent effector cell that kills microorganisms and tumor cells. They produce pro-inflammatory cytokines IL12 in high amounts.2 Studies showed that there was less melanin secretion in the presence of M1 macrophages but increased in the presence of M2 macrophages.3 Additionally, high melanin content could lead to high metastatic potential in UM.4 TRP1 (Tyrosine Related Protein 1) regulates eumelanin synthesis in the Asian population. The oncogenic potential of TAMs in association with pigmentation has not been investigated in UM in the Asian population. Therefore, our study aimed to detect the prognostic significance of TAMs and TYRP1 expression levels in UM patients. Methods Fluorescence In Situ Hybridization (FISH) to detect monosomy 3 was done on 40 UM tissue samples. Immunohistochemistry (IHC) of CD68, CD163 & TRP1 was performed on all UM tissue samples. mRNA expression level of TRP1 was measured by qRT-PCR in all fresh UM cases. ELISA was performed to quantify the expression of IL-10 and IL-12 in UM patients’ serum samples. Cox proportional hazard model and log-rank test were used to determine the prognostic outcome of these markers. Results Infiltrating macrophages in UM cases were predominantly of M2 phenotype. The density of CD163 cells was significantly increased in UM with monosomy 3 and high TRP1 expression compared to disomy 3 and loss of TRP1. Expression of CD163 and TRP1 was correlated with high pigmentation and BAP1 loss. Moreover, UM cases showed high IL10 concentration in comparison to the normal choroid. No significant changes in IL-12 concentration were observed. High expression of TRP1 protein showed reduced disease-free survival (pConclusions Our study showed that high pigmentation might affect the tumor microenvironment in UM by increasing the densities of M2 macrophages leading to tumor progression. This might have a role in the absence of effective antitumor immune responses in UM patients. Our study could provide the development of new therapeutic options that can overcome the immunosuppressive effects. Acknowledgements Jayanti Jha is thankful to the Indian Council of Medical Research for providing SRF (Senior Research Fellowship). References Herwig MC, Bergstorm C, Wells JR, et al. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Eye Res. 2013;107:52–58. Wang YC, He F, Feng F, et al. Notch Signaling Determines the M1 versus M2 Polarization of Macrophages in Antitumor Immune Responses. Cancer Res. 2010;70. Han H, Kim Y, Mo H, et al. Preferential stimulation of melanocytes by M2 macrophages to produce melanin through vascular endothelial growth factor. Scientific Reports. 2022;12:6416. Kashyap S, Singh MK, Jha J, et al. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma. Human Cell. 2020. https://doi.org/10.1007/s13577–020-00397–9. Ethics Approval Ethical approval was obtained from the Institute’s Ethical Committee, All India Institute of Medical Sciences. (approval ID# IECPG-501/17.07.2019) Consent Written informed consent was obtained from all patients before participation in this study.

  • Humidification potential of five plants inhabiting arid zone of Rajasthan

    by Seema Sen, Rachana Dinesh, S. Sundaramoorthy

  • Ocular surface characteristics in pediatric vernal keratoconjunctivitis: a clinico-cytological study

    by Shilpa Sabu, Noopur Gupta, Nimmy Raj, Arnav Panigrahi, Neiwete Lomi, Murugesan Vanathi, Praveen Vashist, Seema Sen, Radhika Tandon


  • Recurrence in Reis Bücklers corneal dystrophy

    by Murugesan Vanathi, Alisha Kishore, Yogita Gupta, Prithvi Bheemanna Setty, Seema Sen, Tapas C Nag, Ranjan Gupta, Arundati Sharma, Radhika Tandon

    We report a case series highlighting clinical correlation of recurrence of Reis–Bucklers corneal dystrophy (RBCD) with histopathology (HPE), genetic analysis, and electron microscopy (EM). This was an interventional case series of three cases in three generations of one family. The index case was a 23-year-old male with bilateral recurrent RBCD following OD PTK and OS ALTK done 6 years earlier. His father had undergone OU PK. His 35-year-old sister and 9-year-old niece were also affected who underwent OU ALTK. Clinical examination, histopathological examination (HPE), and electron microscopy (EM) evaluation were done. The recurrence of RBCD was noted in one of the three members of the same family. Corneal examination showed a dense reticulate pattern of epithelial-stromal involvement. On HPE, disrupted Bowman's membrane and underlying abnormal subepithelial collagen staining positive with PAS and Masson's trichrome were noted. On EM, degenerated stroma with dense collagen fibrils in aggregates, dispersed among regular collagen fibrils, were noted. All four members showed TGFß1 mutation (chromosome 5q31) with Arg124Leu mutation. A trend toward more advanced presentation with increasing age of cases was noted. The clinical and pathological correlation was performed. Clinical correlation with HPE, EM with genetic analysis of RBCD is interesting with presentation severity varying in different generations.

  • Correlation of histopathology of trabecular meshwork with clinical features in primary congenital glaucoma

    by Rinky Agarwal, Seema Sen, Seema Kashyap, Tanuj Dada, Tapas Chandra Nag, Viney Gupta, Ramanjit Sihota

    Purpose: To correlate histopathological changes of trabecular meshwork (TM) with clinical features in primary congenital glaucoma (PCG).Methods: This was a prospective interventional study including 66 eyes of 39 PCG children aged ≤12 months at diagnosis. Corneal clarity, corneal diameter (CD), intraocular pressure (IOP) and cup disc ratio (C:D ratio) were assessed at baseline and at 1-year follow-up. The trabecular meshwork (TM) specimens obtained during primary combined trabeculectomy and trabeculotomy augmented with Mitomycin-C were evaluated on light microscopy to look for eosinophilic membrane (EM), status of trabecular beams and trabecular endothelial cells (TEC), presence of intervening spaces, TM thickness and TEC count which were then correlated with clinical features.Results: At 1-year follow-up, IOP reduced from 27.96±10.2 to 11.88±5.63 mm Hg, p20 mm Hg at presentation (1.86±0.7 mm vs 1.3±0.47 mm, p=0.0356). Eyes with IOP ≤14 mm Hg at final follow-up had lower TEC count than eyes with IOP >14 mm Hg (0.92±0.45 cells/mm2 vs 1.00±0.74 cells/mm2, p=0.0028).Conclusion: A light microscopic analysis of surgical specimens may guide prognosis of PCG. However, larger studies are required to validate these results.


  • Efficacy and Safety of Topical Chloroquine in Mild to Moderate Dry Eye Disease

    by Jeewan S. Titiyal, Manpreet Kaur, Ruchita Falera, Ashima Bharghava, Ramkishor Sah, Seema Sen

    Purpose: To evaluate the role of topical chloroquine (CHQ) as an adjunct to topical lubricants in the management of mild-moderate dry eye disease (DED) Methods: Prospective comparative pilot study allocated 150 patients with symptoms of mild to moderate DED to receive topical CMC 0.5% three times a day (group I, n=75) or topical CHQ 0.03% twice a day with carboxymethylcellulose (CMC) 0.5% three times a day (group II, n=75), for three months. Primary outcome measures were ocular surface disease index (OSDI) score and conjunctival impression cytology at 3 months. Secondary outcome measures were TBUT, Schirmer’s test, ocular surface staining and any adverse effects at 3 months. Follow up was performed at 1 and 3 months. Results: At three months, the OSDI score was significantly better in the CHQ group as compared with the CMC group [CMC-18.36 ± 4.03 (SD), CHQ group- 15.9 ± 5.18 (SD); p=0.002). Nelson’s score was 0.92 ± 0.69 (SD) in the CHQ group as compared with 1.60 ± 0.77 (SD) in the CMC group (p<0.001). Abnormal impression cytology was observed in 20% cases in the CHQ group as compared with 61.3% cases in CMC group (p<0.001). A significant correlation was observed between Nelson’s score and OSDI (Spearman’s rho correlation coefficient 0.414, p<0.001). TBUT, Schirmer test and ocular surface staining were significantly better in the CHQ group (p<0.001). No adverse effects were observed in any group. Conclusion: Topical chloroquine is a useful adjunct to topical lubricants in the management of DED as it decreases the underlying chronic inflammation and helps maintain ocular surface stability.


  • Open Access

    Conjunctival angiomyxoma—rare but needs observation

    by Amar Pujari, Mandeep S. Bajaj, Seema Sen, Siddhi Goel


  • Open Access

    Cystic pleomorphic adenoma of the lacrimal gland: a clinicopathologic study

    by Neelam Pushker, Seema Kashyap, Seema Sen, Mandeep S. Bajaj, Maya Hada